Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP946755.RA2Qjkvn3LJ0J-jb0DJPEE3wrMNrrF3Xv52oUOYX_71Ho130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP946755.RA2Qjkvn3LJ0J-jb0DJPEE3wrMNrrF3Xv52oUOYX_71Ho130_assertion type Assertion NP946755.RA2Qjkvn3LJ0J-jb0DJPEE3wrMNrrF3Xv52oUOYX_71Ho130_head.
- NP946755.RA2Qjkvn3LJ0J-jb0DJPEE3wrMNrrF3Xv52oUOYX_71Ho130_assertion description "[Patients with MTC in remission (n=24) or in persistence (n=18), RET gene mutations carriers (n=14), patients with nodular goiter (n=69), and healthy volunteers (n=16) were submitted to pentagastrin and Ca (25 mg/kg) tests.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946755.RA2Qjkvn3LJ0J-jb0DJPEE3wrMNrrF3Xv52oUOYX_71Ho130_provenance.
- NP946755.RA2Qjkvn3LJ0J-jb0DJPEE3wrMNrrF3Xv52oUOYX_71Ho130_assertion evidence source_evidence_literature NP946755.RA2Qjkvn3LJ0J-jb0DJPEE3wrMNrrF3Xv52oUOYX_71Ho130_provenance.
- NP946755.RA2Qjkvn3LJ0J-jb0DJPEE3wrMNrrF3Xv52oUOYX_71Ho130_assertion SIO_000772 22170709 NP946755.RA2Qjkvn3LJ0J-jb0DJPEE3wrMNrrF3Xv52oUOYX_71Ho130_provenance.
- NP946755.RA2Qjkvn3LJ0J-jb0DJPEE3wrMNrrF3Xv52oUOYX_71Ho130_assertion wasDerivedFrom befree-2016 NP946755.RA2Qjkvn3LJ0J-jb0DJPEE3wrMNrrF3Xv52oUOYX_71Ho130_provenance.
- NP946755.RA2Qjkvn3LJ0J-jb0DJPEE3wrMNrrF3Xv52oUOYX_71Ho130_assertion wasGeneratedBy ECO_0000203 NP946755.RA2Qjkvn3LJ0J-jb0DJPEE3wrMNrrF3Xv52oUOYX_71Ho130_provenance.